Back to Search
ANNA CHOLLET M.D.
M.D.
Family Medicine Physician
NPI: 1457626905IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
DR.0065761(CO)52684(TN)
Education
TULANE UNIVERSITY SCHOOL OF MEDICINE
Class of 2012
Research & Publications (15)
Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
PMID 18318469·J Med Chem·2008
7-preclinical
Intravenous regional anesthesia administered by the operating plastic surgeon: is it safe and efficient? Experience of a medical center.
PMID 18040193·Plast Reconstr Surg·2007
8-other
Arrest of preterm labor in rat and mouse by an oral and selective nonprostanoid antagonist of the prostaglandin F2alpha receptor (FP).
PMID 17618756·Am J Obstet Gynecol·2007
3-trial
Tocolytic effect of a selective FP receptor antagonist in rodent models reveals an innovative approach to the treatment of preterm labor.
PMID 17570160·BMC Pregnancy Childbirth·2007
7-preclinical
Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins.
PMID 16845676·Glia·2006
7-preclinical
Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists.
PMID 16302826·J Med Chem·2005
7-preclinical
Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.
PMID 12930146·J Med Chem·2003
7-preclinical
Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor.
PMID 12660315·J Pharmacol Exp Ther·2003
7-preclinical
Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate.
PMID 14511330·Eur J Neurosci·2003
4-observational
Identification of the extracellular loop 2 as the point of interaction between the N terminus of the chemokine MIP-1alpha and its CCR1 receptor.
PMID 12181451·Mol Pharmacol·2002
7-preclinical
Solid-phase synthesis of alpha-substituted 3-bisarylthio N-hydroxy propionamides as specific MMP inhibitors.
PMID 11814839·Bioorg Med Chem·2002
7-preclinical
Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5.
PMID 11170631·J Med Chem·2001
7-preclinical
Chemical analysis of lipid-modified membrane proteins in Acholeplasma laidlawii.
PMID 11685510·Curr Microbiol·2001
8-other
General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.
PMID 11212095·Bioorg Med Chem Lett·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via CATHOLIC HEALTH INIATIVES COLORADO · 3 locations total
- Address
- 1338 PHAY AVE BLDG D
CANON CITY, CO 81212 - Phone
- (719) 285-2700
Quick Facts
- NPI
- 1457626905
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 14
- Publications
- 15
Are you this provider?
Claim Your Profile